For citations:
Volkov A.V., Martynyuk T.V., Yudkina N.N., Danilov N.M., Reshetnyak T.M., Chazova I.E., Nasonov E.L. The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases. Rheumatology Science and Practice. 2011;49(6):22-27. (In Russ.) https://doi.org/10.14412/1995-4484-2011-515